Lommatzsch P
Mod Probl Ophthalmol. 1977;18:128-36.
Therapeutic results after beta-irradiation suggest that 106Ru/106Rh applicators have become an acceptable means of radiotherapy in patients suffering from retinoblastoma with a height of not exceeding 5 mm. Because of the rapid fall-off radiation dose it is possible to deliver a high dosage to the tumor without danger of radiogenic damage to the whole globe. Out of 22 children suffering from retinoblastoma a complete destruction and scarification of the tumor could be obtained in 18 eyes with sufficient vision acuity over a follow-up period of more than 5 years. In 4 cases an additional photocoagulation was necessary. beta-Irradiation avoids an undesirable high-volume dose. It may, therefore, be regarded as a useful contribution to radiotherapy of retinoblastoma.
β射线照射后的治疗结果表明，对于高度不超过5mm的视网膜母细胞瘤患者，106Ru/106Rh敷贴器已成为一种可接受的放射治疗手段。由于辐射剂量迅速下降，有可能在不危及整个眼球放射性损伤的情况下向肿瘤输送高剂量。在22例视网膜母细胞瘤患儿中，18只眼在超过5年的随访期内肿瘤完全破坏并形成瘢痕，视力足够。4例需要额外进行光凝治疗。β射线照射可避免不必要的高体积剂量。因此，它可被视为对视网膜母细胞瘤放射治疗的一项有益贡献。
